EU antitrust regulators are seeking feedback from interested parties before deciding whether to scrutinise small merger deals that give companies access to valuable data or high-potential drugs.
European Competition Commissioner Margrethe Vestager flagged the move last week, underlining the possibility of some companies acquiring data-rich rivals to lock in users and exclude competitors.
EU merger rules now apply only to deals where the combined businesses exceed specific thresholds in terms of annual global and EU-wide turnover.
The European Commission said it may include other criteria, such as a high purchase price or high-value biotech products under development, depending on the results of the consultation launched on Friday.
“There have been suggestions to complement the existing thresholds by other alternative criteria in order to capture some types of transactions in certain sectors, for example digital services and pharmaceuticals,” the EU antitrust enforcer said in a statement.
The consultation, which runs until Jan. 13, could also lead to simpler rules for straightforward merger deals.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas